Skip to main content

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

Volume 12, Number 7, July 2011

Articles

Metabolic Profiling in Disease Diagnosis, Toxicology and Personalized Healthcare
pp. 976-995(20)
Authors: Anas Kamleh, M.; Spagou, Konstantina; J. Want, Elizabeth

Favourites:
ADD
Favourites:
ADD

Harnessing Metabolomics for Nutrition Research
pp. 1005-1015(11)
Authors: A. Zulyniak, Michael; M. Mutch, David

Favourites:
ADD

Lipid Mediator Profiling in Pulmonary Disease
pp. 1026-1052(27)
Authors: L. Lundstrom, Susanna; Balgoma, David; M. Wheelock, Asa; Z. Haeggstrom, Jesper; Dahlen, Sven-Erik; E. Wheelock, Craig

Favourites:
ADD

How Unbiased is Non-Targeted Metabolomics and is Targeted Pathway Screening the Solution?
pp. 1053-1066(14)
Authors: Christians, Uwe; Klawitter, Jelena; Hornberger, Andrea; Klawitter, Jost

Favourites:
ADD

Volatile Disease Biomarkers in Breath: A Critique
pp. 1067-1074(8)
Authors: Kwak, Jae; Preti, George

Favourites:
ADD

Elucidation of Cellular Metabolism Via Metabolomics and Stable-Isotope Assisted Metabolomics
pp. 1075-1086(12)
Authors: Hiller, Karsten; Metallo, Christian; Stephanopoulos, Gregory

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more